Istradefylline

Istradefylline
Systematic (IUPAC) name
8-[(E)-2-(3,4-dimethoxyphenyl)vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione
Identifiers
CAS Number 155270-99-8 YesY
ATC code none
PubChem CID 5311037
IUPHAR/BPS 5608
ChemSpider 4470574 YesY
UNII 2GZ0LIK7T4 YesY
KEGG D04641 YesY
ChEMBL CHEMBL431770 YesY
Chemical data
Formula C20H24N4O4
Molar mass 384.429 g/mol
  (verify)

Istradefylline (KW-6002) is a selective antagonist at the A2A receptor. It has been found to be useful in the treatment of Parkinson's disease.[1] Istradefylline reduces dyskinesia resulting from long-term treatment with classical antiparkinson drugs such as levodopa. Istradefylline is an analog of caffeine.

References

  1. Peter A. LeWitt, MD, M. Guttman, James W. Tetrud, MD, Paul J. Tuite, MD, Akihisa Mori, PhD, Philip Chaikin, PharmD, MD, Neil M. Sussman, MD (2008). "Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces off time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)". Annals of Neurology 63 (3): 295–302. doi:10.1002/ana.21315. PMID 18306243.



This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.